Viking Therapeutics, Inc.
Clinical trials sponsored by Viking Therapeutics, Inc., explained in plain language.
-
New Weight-Loss shot shows promise in major trial
Disease control OngoingThis study tests an experimental drug called VK2735 to help people with obesity or overweight lose weight. About 4500 adults without diabetes will receive weekly injections of the drug or a placebo for 78 weeks. The main goal is to see how much weight they lose and if the treatme…
Phase: PHASE3 • Sponsor: Viking Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New shot could help diabetics shed pounds in 78-Week trial
Disease control OngoingThis study tests a new weekly injection called VK2735 to help adults with type 2 diabetes who are overweight or obese lose weight. About 1,100 participants will receive either the drug or a placebo for 78 weeks. The main goal is to see how much weight they lose and if the treatme…
Phase: PHASE3 • Sponsor: Viking Therapeutics, Inc. • Aim: Disease control
Last updated May 06, 2026 16:13 UTC